$nvos
NVO's Wegovy pill distribution shows a significant portion of patients are new to GLP-1s, while others are switching from injectable Wegovy or Zepbound. Discussions highlight the potential for market underestimation of NVO's innovations in diabetes and weight management.
About $nvos
$NVO is a cryptocurrency project focused on pharmaceutical developments, particularly in diabetes and weight management treatments.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Month: [-------] +5%
[--] Months: [---------] +132%
[--] Year: [---------] -56%
1-Year High: [-------] on 2025-12-02
1-Year Low: [--] on 2025-05-26
Engagements by network (24h): Reddit: [--] X: [-----]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-11-21
1-Year Low: [--] on 2025-09-16
Mentions by network (24h): Reddit: [--] X: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $nvos in the last [--] hours which is up 9.10% from [--] in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-12-24
1-Year Low: [--] on 2025-09-16
The most influential creators that mention $nvos in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @comeontothemoon | [--] | [---] | [--] | [---] |
| @LouBasenese | [--] | [-----] | [--] | [---] |
| @Rocket_Labs22 | [--] | [---] | [--] | [--] |
| @LucyTrader98 | [--] | [---] | [--] | [--] |
Sentiment: 67%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 67%
Daily Average: 78%
[--] Month: 70% +3%
[--] Months: 70% -21%
[--] Year: 70% -1%
1-Year High: 100% on 2025-02-21
1-Year Low: 15% on 2025-06-10
Most Supportive Themes:
- Diabetes and Weight Management Treatments: (50%) Focus on pharmaceutical developments in diabetes and weight management.
- Wegovy Pill Performance: (25%) Early sales and effectiveness data for Wegovy pill in weight loss.
- Market Underestimation of Innovations: (25%) Analysis suggesting the market has not fully priced in key company innovations.
Most Critical Themes:
Top $nvos Social Posts
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"@DeepIceValue Funds increasing their positions may signal confidence in $NVO's long-term growth potential. Monitoring its fundamentals can provide more investment insights"
X Link @william_R2Rclub 2026-02-14T20:00Z [----] followers, [---] engagements
"@Pharmdca I really hope Brian can start providing some color on MASH program also. Just looking at $MDGL I think they truly have an exceptional pipeline with late stage clinical data across most programs. I am still a bit on the fence about their amylin asset in light of $NVO's resutls"
X Link @Cricket99238 2026-02-13T23:20Z [---] followers, [---] engagements
"When you don't agree with your friend you debate him Join @danielnewmanUV and me today at 4pm ET live on @X. He'll defend $HIMS - the worst performing stock in [----]. I'll defend $NVO's business but not the stock. $HIMS is correct. Stopping compounding is a pharma brigade move to control a key aspect to the future of medicine. Peptides. And if it succeeds it will limit access to these game changing inexpensive protocols that help improve wellness and eliminate the need for certain $HIMS is correct. Stopping compounding is a pharma brigade move to control a key aspect to the future of medicine."
X Link @LouBasenese 2026-02-13T16:31Z [----] followers, [----] engagements
"Wegovy pill data. Here is some data on prior experiences with GLP1. Excluding those who didnt answer almost [--] out of [--] came with Zepbound/mounjaro experience. However we need more data for context. We already know only about 12% of wegovy pill consumers have started with a higher dose than 1.5mg. That means 12% shifted directly from another GLP1. Those are the most interesting to know what they shifted from. The rest who have mentioned prior experience with Zepbound have likely stopped Zepbound for losing insurance and couldnt afford cash price for Zepbound vials. Theres definitely also some"
X Link @ResearchPulse1 2026-02-13T07:37Z [----] followers, [----] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing